Percutaneous cementoplasty for palliative treatment of bony malignancies

Current evidence on the safety and efficacy of percutaneous cementoplasty for the palliative treatment of bony malignancies is limited, but appears adequate to support the use of this procedure in patients for whom other treatments have failed, provided that the normal arrangements are in place for consent, audit and clinical governance.

Patient selection should be carried out in the context of a multidisciplinary team, which may include specialists in radiology, oncology, radiotherapy, orthopaedics, pain management and palliative care.